ASND

Ascendis Pharma A/SNASDAQHealthcare

$229.25+0.44%ClosedMarket Cap: $14.07B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-03	RBC Capital	—	Outperform	—
2026-02-12	Oppenheimer	—	Outperform	—
2026-02-12	Wedbush	—	Outperform	—
2026-01-30	B of A Securities	—	Buy	—
2026-01-20	RBC Capital	—	Outperform	—
2026-01-20	Wells Fargo	—	Overweight	—
2026-01-07	TD Cowen	—	Buy	—
2025-12-11	Stifel	—	Buy	—
2025-11-18	Wedbush	—	Outperform	—
2025-10-13	Cantor Fitzgerald	—	Overweight	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$10.63	$2.00B	11
Sun Dec 31	$15.98	$2.55B	7
Mon Dec 31	$20.20	$3.08B	2
Tue Dec 31	$23.16	$3.44B	5